News and Press Releases - Geron Corporation

The latest from Geron.

Company news, financial updates, scientific presentations, and events as we advance treatments for people living with blood cancer.

Press releases

Geron Corporation Provides Update on Phase 3 IMpactMF Clinical Trial of Imetelstat in Relapsed/Refractory Myelofibrosis

October 28, 2026

Geron Plans to Announce Third Quarter 2026 Financial Results on November 4, 2026

October 21, 2026

Geron Corporation Announces Oral Presentations Highlighting Imetelstat at International Hematology Congresses in Europe and Asia

Presentations feature real-world experience and clinical evidence in lower-risk MDS, underscoring growing global scientific engagement with imetels…

October 12, 2026

Geron to Present at Upcoming Investor Conferences

September 2, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 18, 2026

Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Geron Announces Appointment of Chinmaya Rath as Chief Business Officer

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

view all of Geron’s past releases

Events

Q3 2026 Geron Earnings Conference Call

November, 4, 2026 8:00 AM EDT

H.C. Wainwright 28th Annual Global Investment Conference

September 15, 2026 , 3:30 p.m. ET

2026 Cantor Global Healthcare Conference

September 9, 2026 8:00 a.m. ET

Q2 2026 Geron Earnings Conference Call

August 5, 2026 8:00 AM EDT

Goldman Sachs 47th Annual Global Healthcare Conference

June 8, 2026 8:40 AM EDT

2026 Stifel Virtual Targeted Oncology Forum

May 20, 2026 12:00 PM EDT